Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies
- PMID: 26269373
- DOI: 10.3945/ajcn.115.109165
Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies
Abstract
Background: Whole grains are recognized for their potential role in preventing cardiovascular diseases; however, results from randomized controlled studies on blood lipids are inconsistent, potentially because of compositional differences between individual grain types for some nutrients, including dietary fiber.
Objective: Using a meta-analytic approach, we assessed the effect of whole-grain compared with non-whole-grain foods on changes in total cholesterol (TC), LDL cholesterol, HDL cholesterol, and triglycerides.
Design: We conducted a systematic literature search in selected databases. Studies were included if they were randomized controlled comparisons between whole-grain foods and a non-whole-grain control in adults. A total of 6069 articles were screened for eligibility, and data were extracted from 24 studies. Weighted mean differences were calculated, and meta-regression analyses were performed for whole-grain dose, study duration, and baseline TC concentration.
Results: Overall, whole-grain intake lowered LDL cholesterol (weighted difference: -0.09 mmol/L; 95% CI: -0.15, -0.03 mmol/L; P < 0.01) and TC (weighted difference: -0.12 mmol/L; 95% CI: -0.19, -0.05 mmol/L; P < 0.001) compared with the control. Whole-grain oat had the greatest effect on TC (weighted difference: -0.17 mmol/L; 95% CI: -0.10, -0.25 mmol/L; P < 0.001). No effect of whole-grain foods on HDL cholesterol was seen, whereas whole-grain foods tended to lower triglycerides compared with the control (weighted difference: -0.04 mmol/L; 95% CI: -0.08, 0.01; P = 0.10). No association was found between whole-grain dose or baseline TC concentration and any of the outcomes, whereas study duration was positively associated with changes in TC and LDL cholesterol.
Conclusions: Consumption of whole-grain diets lowers LDL cholesterol and TC, but not HDL cholesterol or triglycerides, compared with consumption of non-whole-grain control diets. Whole-grain oat appears to be the most effective whole grain for lowering cholesterol.
Keywords: LDL cholesterol; cardiovascular disease; cereals; dietary fiber; lipidemia; total cholesterol; whole grains.
© 2015 American Society for Nutrition.
Similar articles
-
Total red meat intake of ≥0.5 servings/d does not negatively influence cardiovascular disease risk factors: a systemically searched meta-analysis of randomized controlled trials.Am J Clin Nutr. 2017 Jan;105(1):57-69. doi: 10.3945/ajcn.116.142521. Epub 2016 Nov 23. Am J Clin Nutr. 2017. PMID: 27881394 Free PMC article. Review.
-
Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial.Nutrients. 2016 Sep 7;8(9):549. doi: 10.3390/nu8090549. Nutrients. 2016. PMID: 27618090 Free PMC article. Clinical Trial.
-
Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials.Am J Clin Nutr. 2014 Dec;100(6):1413-21. doi: 10.3945/ajcn.114.086108. Epub 2014 Oct 15. Am J Clin Nutr. 2014. PMID: 25411276 Free PMC article.
-
Effects of low-fat diet on serum lipids in premenopausal and postmenopausal women: a meta-analysis of randomized controlled trials.Menopause. 2014 Jan;21(1):89-99. doi: 10.1097/GME.0b013e318291f5c2. Menopause. 2014. PMID: 23736858 Review.
-
Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.J Am Diet Assoc. 2010 Feb;110(2):205-14. doi: 10.1016/j.jada.2009.10.037. J Am Diet Assoc. 2010. PMID: 20102847 Clinical Trial.
Cited by
-
Validation of Nutritional Approaches to Modulate Cardiovascular and Diabetic Risk Factors in Patients with Hypertriglyceridemia or Prediabetes-The MoKaRi II Randomized Controlled Study.Nutrients. 2024 Apr 24;16(9):1261. doi: 10.3390/nu16091261. Nutrients. 2024. PMID: 38732508 Free PMC article. Clinical Trial.
-
Consumption of dietary fiber and APOA5 genetic variants in metabolic syndrome: baseline data from the Korean Medicine Daejeon Citizen Cohort Study.Nutr Metab (Lond). 2024 Apr 5;21(1):19. doi: 10.1186/s12986-024-00793-0. Nutr Metab (Lond). 2024. PMID: 38581036 Free PMC article.
-
Whole-grain intake in mid-life and healthy ageing in the Danish Diet, Cancer and Health cohort.Eur J Nutr. 2024 Mar 7. doi: 10.1007/s00394-024-03357-3. Online ahead of print. Eur J Nutr. 2024. PMID: 38451283
-
Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders.Front Nutr. 2023 Dec 15;10:1291853. doi: 10.3389/fnut.2023.1291853. eCollection 2023. Front Nutr. 2023. PMID: 38192650 Free PMC article. Review.
-
Low-Carbohydrate and Low-Fat Diet with Metabolic-Dysfunction-Associated Fatty Liver Disease.Nutrients. 2023 Nov 13;15(22):4763. doi: 10.3390/nu15224763. Nutrients. 2023. PMID: 38004162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical